Effect of diabetes on pinacidil-induced antinociception in mice

European Journal of Pharmacology

Volumn 453, Issue 2-3, 2002, Pages 209-215

  Zushida, Ko ^a   Onodera, Kenji ^b   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Antinociception; ATP sensitive K+i channel; Diabetes; Opioid receptor; Pinacidil

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 7 BENZYLIDENENALTREXONE; BETA FUNALTREXAMINE; BINALTORPHIMINE; DELTA OPIATE RECEPTOR; GLIBENCLAMIDE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALTRIBEN; PINACIDIL; POTASSIUM CHANNEL; NARCOTIC ANTAGONIST; VASODILATOR AGENT;

ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; EXPERIMENTAL DIABETES MELLITUS; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRASPINAL DRUG ADMINISTRATION; PAIN;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYBURIDE; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED ICR; NARCOTIC ANTAGONISTS; PAIN; PINACIDIL; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; VASODILATOR AGENTS;

EID: 0037174808     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02429-9     Document Type: Article

References (38)

1. Aguilar-Bryan L., Nichols C.G., Wechsler S.W., Clement J.P., Boyd A.E., Gonzalez G., Herrerasosa H., Nguy K., Brayan J., Nelson D.A. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science. 268:1995;423-426.
2. + channels. Science. 247:1990;852-854.
3. +-channels. Cell. Signal. 2:1990;197-214.
4. Ashford M.L.J., Sturgess N.C., Trout N.J., Gardner N.J., Hale C.N. Adenosine-5′-triphosphate-sensitive ion channels in neonatal rat cultured central neurones. Pflugers Arch. 412:1990;297-304.
5. + channels sensitive to antidiabetic sulfonylureas are present in adenohypophysis and are involved in growth hormone release. Proc. Natl. Acad. Sci. U. S. A. 90:1993;1340-1344.
6. + channels and their probable role for the membrane potential of mouse motor nerve endings. Pflugers Arch. 421:1992;292-294.
7. Finta E.P., Harms L., Sevik J., Fisher H.D., Illes P. Effects of potassium channel openers and their antagonists on rat locus coeruleus. Br. J. Pharmacol. 109:1993;308-315.
8. Haley M.J., McCormik W.G. Pharmacological effects produced by intracerebral injection of drug in the conscious mice. Br. J. Pharmacol. 12:1957;12-15.
9. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:1980;313-316.
10. Inagaki N., Gonoi T., Clement J.P., Namba N., Inazawa J., Gonzalez G., Nichols C.G., Wechsler S.W., Clement J.P., Boyd A.E., Gonzalez G., Aguilar-Bryan L., Seino S., Brayan J. Reconstitution of I-KATP: an inward rectifier subunit plus the sulfonylurea receptor. Science. 270:1995;1166-1170.
11. Kamei J., Kawashima N., Kasuya Y. Role of spleen or spleen products in the deficiency in morphine induced analgesia in diabetic mice. Brain Res. 576:1992;139-142.
12. Kamei J., Kawashima N., Kasuya Y. Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of δ-opioid receptor. Brain Res. 592:1992;101-105.
13. Kamei J., Ohhashi Y., Aoki T., Kawashima N., Kasuya Y. Streptozotocin induced diabetes selectively alters the potency of analgesia produced by δ opioid agonists, but not by μ and κ opioid agonists. Brain Res. 571:1992;199-203.
14. Kamei J., Kawashima N., Hitosgi H., Misawa M., Nagase H., Kasuya Y. Effect of diabetes on the antinociceptive effect of β endorphin. Brain Res. 619:1993;76-80.
15. 2-opioid receptors. Neurosci. Lett. 165:1994;141-143.
16. 2-opioid receptors. Life Sci. 55:1994;PL121-PL126.
17. Kamei J., Kawashima N., Narita M., Suzuki T., Misawa M., Kasuya Y. Reduction in ATP-sensitive potassium channel-mediated antinociception in diabetic mice. Psychopharmacology. 113:1994;318-321.
18. Kamei J., Saito A., Ohsawa M., Suzuki T., Misawa M., Nagase H., Kasuya Y. Antinociceptive effects of the selective non-peptidic δ-opioid agonist TAN-67 in diabetic mice. Eur. J. Pharmacol. 276:1995;131-135.
19. 1-opioid receptor-mediated antinociceptive properties (-)-TAN-67 in diabetic mice. Eur. J. Pharmacol. 322:1997;27-30.
20. Kamei J., Zushida K., Ohsawa M., Nagase H. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice. Eur. J. Pharmacol. 391:2000;91-96.
21. + channel opener-induced antinociception. Eur. J. Pharmacol. 384:1999;147-152.
22. + channel openers enhance opioid antinociception: in direct evidence for the release of endogenous opioid peptides. Eur. J. Pharmacol. 385:1999;119-127.
23. Moure C., Ben Ari Y., Beernardi H., Fosset M., Lazdunski M. Antidiabetic sulfonylureas: localization of binding sites in the brain and effects on the hyperpolarization induced by anoxia in hippocampal slices. Brain Res. 486:1989;159-164.
24. + channels in guinea-pig sustantia nigra revealed by responses to anoxia. J. Physiol. 453:1992;167-183.
25. + channels produces the antinociception and spinal noradrenaline turnover-enhancing effect in mice. Psychopharmacology. 113:1993;11-14.
26. + channel-acting drugs. Br. J. Pharmacol. 114:1995;1296-1302.
27. + channel in rat cultured cortical neurons. Pflugers Arch. 422:1992;260-266.
28. Ohsawa M., Kamei J. Possible involvement of spinal protein kinaseC in the thermal allodynia and hyperalgesia in diabetic mice. Eur. J. Pharmacol. 372:1999;221-228.
29. + channels. Trends Pharmacol. Sci. 10:1989;431-435.
30. B receptors in isolated sustantia nigra neurons. Pflugers Arch. 416:1990;473-475.
31. Sakura H., Ämmälä C., Smith P.A., Gribble F.M., Ashcroft F.M. Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic b-cells, brain, heart and skeletal muscle. FEBS Lett. 377:1995;338-344.
32. + channels mediate an IPSP in dorsal horn neurons elicited by sensory stimulation. Synapse. 11:1992;214-220.
33. + channels and block neurosecretion. Proc. Natl. Acad. Sci. U. S. A. 87:1990;3489-3492.
34. Suzuki Y., Goto K., Shiizaki K., Omiya Y., Ishige A., Komatsu Y., Kamei J. Antinociceptive effect of U-50488H, a κ-opioid agonist, in streptozotocin-induced diabetic mice. Jpn. J. Pharmacol. 79:2001;169-175.
35. Tallarida R.J., Murray R.B. Manual of Pharmacologic Calculations with Computer Programs. 2nd ed. 1987;Springer-Verlag, New York, NY.
36. Welch S.P., Dunlow L.D. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action? J. Pharmacol. Exp. Ther. 267:1993;390-399.
37. Yamashita S., Park J.B., Ryu P.D., Inukai H., Tanifuji M., Murase K. Possible presence of the ATP-sensitive K+channel in isolated spinal dorsal horn neurons of the rat. Neurosci. Lett. 170:1994;208-212.
38. Zhang L., Bonev A., Nelson M.T., Mawe G.M. CGRP activates ATP-sensitive potassium currents in gallbladder smooth muscle. Soc. Neurosci. Abstr. 19:1993;479.